Purpose of review To highlight the latest evidence supporting management recommenda- tions in anaphylaxis and discuss the implications for further research in anaphylaxis management. Recent findings The acute management of anaphylaxis is largely centered on resuscitation and administration of epinephrine. There is little evidence to support the use of antihis- tamines and corticosteroids in the acute management of anaphylaxis. Summary Anaphylaxis is an acute, systemic, potentially life-threatening reaction caused by the release of mast cell and basophil mediators that could lead to distributive shock. Anaphylaxis is associated with increased healthcare utilization and costs. The definition of anaphylaxis is largely based on clinical criteria with no validated biomarker confirming the diagnosis. Long-term follow-up is recommended to identify triggers and co-factors of anaphylaxis. Further, this helps to establish a plan for trigger avoidance and emergency action plan to manage subsequent episodes. Given the significant morbidity and mortality associated with this diagnosis, high quality randomized controlled studies are lacking to support management decisions in anaphylaxis. Introduction Anaphylaxis is an acute, systemic, potentially life- mediators that could lead to distributive shock . The threatening reaction that often results in emergency de- lifetime prevalence of anaphylaxis is estimated between partment visits and hospital admissions
Current Treatment Options in Allergy – Springer Journals
Published: Apr 20, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera